DEVELOPMENT OF PHARMACOLOGICAL-ACTIVE COMPOUNDS BASED ON POLYMER COMPLEX FOR TREATMENT AND PREVENTION OF MICROELEMENTS OF FUR ANIMALS

2021 ◽  
pp. 55-60
Author(s):  
Nikolay Aleksandrovich Balakirev ◽  
Alexandr Alexandrovich Deltsov ◽  
Vladimir Il’ich Maksimov
2020 ◽  
Vol 27 ◽  
pp. 00082
Author(s):  
N.A. Balakirev ◽  
V.I. Maximov ◽  
A.A. Deltsov

The analysis of iron-containing products made in Russia for veterinarian use against iron deficiency anaemia in fur farming was carried out. The absence of hydroxide-polymaltose iron complexes on the pharmaceutical market has been shown and their promise as the main components for oral preparations has been substantiated. In this context, the Collective of the Department of Physiology, Pharmacology and Toxicology, FSBEI HE MGAVMiB-MVA named after K.I. Skryabin, in collaboration with the research and production company A-BIO conducted research to develop and study the effect of pharmacologically active compounds based on a polymer (iron-hydroxide polymantose) complex for treatment and prevention of microelemetosis in the fur animals.


Author(s):  
N.А. Balakirev ◽  
◽  
V.I. Maximov ◽  
А.А. Deltsov ◽  
◽  
...  

The key factor of non-infectious diseases of iron deficiency anemia, which slows down the growth and development of fur-bearing animals of various breeds, is a violation of iron metabolism in the body, which leads to a deterioration in the condition and quality of furs. This is due to the fact that iron is an essential element by which most of the processes and functions in the body are car-ried out. It has been shown that the use of preparations of ferrous and ferric iron leads to damage not only to the structural elements of the gastrointestinal tract, but also to other systems and organs, which is due to the fact that in the absence of oxygen in the tissues, the reduction of iron from the ferric form to the ferrous form with further transfer electrons from ferrous iron to hydrogen perox-ide causes the formation of a hydroxyl radical, which launches a program for self-destruction. It is proposed to solve the problem of the use of iron preparations for oral use in fur farming, as in-dustries where they are not used enough, to conduct research on the development and study of the effect of physiologically and pharmacologically active compounds based on a polymer (iron-hydroxide polymantose) on fur animals for the treatment and prevention of microelemetosis. It is being solved by the collective of the Department of Physiology, Pharmacology and Toxicology of the Moscow State Academy of Medical Sciences and Biology. Scriabin together with the research and production company LLC Firm "A-BIO" on the basis of an analysis of literary and patent sources, production technologies, pharmacological characteristics of ongoing research to develop and study the effect of physiologically and pharmacologically active compounds based on polymer (iron-hydroxide polymantose) on fur animals in the treatment and prevention of iron deficiency anemia.


2021 ◽  
Vol 2021 ◽  
pp. 1-19
Author(s):  
Bashar Saad ◽  
Bilal Ghareeb ◽  
Abdalsalam Kmail

Ever-growing research efforts are demonstrating the potential of medicinal plants and their phytochemicals to prevent and manage obesity, either individually or synergistically. Multiple combinations of phytochemicals can result in a synergistic activity that increases their beneficial effects at molecular, cellular, metabolic, and temporal levels, offering advantages over chemically synthesized drug-based treatments. Herbs and their derived compounds have the potential for controlling appetite, inhibiting pancreatic lipase activity, stimulating thermogenesis and lipid metabolism, increasing satiety, promoting lipolysis, regulating adipogenesis, and inducing apoptosis in adipocytes. Furthermore, targeting adipocyte life cycle using various dietary bioactives that affect different stages of adipocyte life cycle represents also an important target in the development of new antiobesity drugs. In this regard, different stages of adipocyte development that are targeted by antiobesity drugs can include preadipocytes, maturing preadipocytes, and mature adipocytes. Various herbal-derived active compounds, such as capsaicin, genistein, apigenin, luteolin, kaempferol, myricetin, quercetin, docosahexaenoic acid, quercetin, resveratrol, and ajoene, affect adipocytes during specific stages of development, resulting in either inhibition of adipogenesis or induction of apoptosis. Although numerous molecular targets that can be used for both treatment and prevention of obesity have been identified, targeted single cellular receptor or pathway has resulted in limited success. In this review, we discuss the state-of-the-art knowledge about antiobesity medicinal plants and their active compounds and their effects on several cellular, molecular, and metabolic pathways simultaneously with multiple phytochemicals through synergistic functioning which might be an appropriate approach to better management of obesity. In addition, epigenetic mechanisms (acetylation, methylation, miRNAs, ubiquitylation, phosphorylation, and chromatin packaging) of phytochemicals and their preventive and therapeutic perspective are explored in this review.


2003 ◽  
Vol 56 (8) ◽  
pp. 647-653 ◽  
Author(s):  
Lan Liu ◽  
Stan Duraj ◽  
Phillip E. Fanwick ◽  
Maria T. Andras ◽  
Aloysius F. Hepp

Sign in / Sign up

Export Citation Format

Share Document